SMS Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on August 10, 2016, has transacted the agenda item relating to consideration of Draft scheme of Demerger could not be transacted in this meeting and it was decided by the Board to adjourn the meeting to Saturday, August 13, 2016 at 03:00p.m to have a detailed discussions on the matter.
The above information is a part of company’s filings submitted to BSE.